COVID-19 innovations in medication for addiction treatment at a Skid Row syringe exchange.
COVID-19 innovations in medication for addiction treatment at a Skid Row syringe exchange.
复制标题
DOI：
10.1016/j.jsat.2020.108181
复制
发表时间：
2021-03
影响因子：
3.9
通讯作者：
Subica AM
中科院分区：
文献类型：
--
作者：
Tringale R;Subica AM
洛杉矶贫民窟的注射器交换患者忍受着极度贫困、多种药物使用、潜在的健康问题以及生活在街头或无家可归者营地/避难所等条件，这些条件使他们特别容易感染和死于COVID-19。在这篇评论中，我们讨论了洛杉矶无家可归者医疗中心（HHCLA）为修改现有药物成瘾治疗（MAT）服务而做出的两项基本改变，以满足2019冠状病毒病期间这一高危人群的特定治疗需求。首先，HHCLA实施了一种新颖的“电话亭”模式，允许社会距离远的现场“面对面”治疗注射器交换患者；这一模式帮助我们克服了使用传统远程医疗方法（如视频、移动电话）治疗弱势患者群体的固有挑战。其次，HHCLA从在我们的供应商办公室现场直接分配MAT药物过渡到一种较少接触和时间密集的“协调药房”模式，使患者可以自由地从参与药房获得MAT药物。我们的数据表明，实施这些与COVID-19相关的变化有效地维持了患者对MAT的登记和参与，这为提供MAT提供了新的、潜在的有效模型，以满足COVID-19后注射器交换患者的关键健康和安全需求。
Syringe exchange patients in Los Angeles' Skid Row endure conditions such as deep poverty, polysubstance use, underlying health problems, and living on the streets or in homeless encampments/shelters that make them uniquely vulnerable to acquiring and dying from COVID-19. In this commentary, we discuss two essential changes that Homeless Health Care Los Angeles (HHCLA) made to modify existing medication for addiction treatment (MAT) services to address the specific treatment needs of this high-risk population during COVID-19. First, HHCLA implemented a novel “telephone booth” model that allowed socially distanced on-site “face-to-face” treatment of syringe exchange patients; this model helped us to overcome the inherent challenges of using traditional telemedicine approaches (e.g., video, mobile telephone) with this disadvantaged patient population. Second, HHCLA transitioned from on-site direct dispensing of MAT medications in our providers' offices to a less contact- and time-intensive “coordinated pharmacy” model that allowed patients the freedom to obtain MAT medications off-site from participating pharmacies. Our data indicate that implementing these COVID-19-related changes effectively maintained patient enrollment and engagement in MAT—illuminating new, potentially effective models for delivering MAT that meet the critical health and safety needs of syringe exchange patients following COVID-19.
影响因子：
5.5
作者：
Harris, Miriam;Johnson, Samantha;Taylor, Jessica L.
通讯作者：
Taylor, Jessica L.
影响因子：
4.4
作者：
Dunlop, Adrian;Lokuge, Buddhima;Maher, Lisa
通讯作者：
Maher, Lisa